Mitogen-activated protein kinase signaling mediates opioid-induced presynaptic NMDA receptor activation and analgesic
Meichun Deng1,2, Shao-Rui Chen1, Hong Chen1
1Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abstract:
Opioid-induced hyperalgesia and analgesic tolerance can lead to dose escalation and inadequate pain treatment with μ-opioid receptor agonists. Opioids cause tonic activation of glutamate NMDA receptors (NMDARs) at primary afferent terminals, increasing nociceptive input. However, the signaling mechanisms responsible for opioid-induced activation of pre-synaptic NMDARs in the spinal dorsal horn remain unclear. In this study, we determined the role of MAPK signaling in opioid-induced pre-synaptic NMDAR activation caused by chronic morphine administration. Whole-cell recordings of excitatory post-synaptic currents (EPSCs) were performed on dorsal horn neurons in rat spinal cord slices. Chronic morphine administration markedly increased the frequency of miniature EPSCs, increased the amplitude of monosynaptic EPSCs evoked from the dorsal root, and reduced the paired-pulse ratio of evoked EPSCs. These changes were fully reversed by an NMDAR antagonist and normalized by inhibiting extracellular signal-regulated kinase 1/2 (ERK1/2), p38, or c-Jun N-terminal kinase (JNK). Furthermore, intrathecal injection of a selective ERK1/2, p38, or JNK inhibitor blocked pain hypersensitivity induced by chronic morphine treatment. These inhibitors also similarly attenuated a reduction in morphine's analgesic effect in rats. In addition, co-immunoprecipitation assays revealed that NMDARs formed a protein complex with ERK1/2, p38, and JNK in the spinal cord and that chronic morphine treatment increased physical interactions of NMDARs with these three MAPKs. Our findings suggest that opioid-induced hyperalgesia and analgesic tolerance are mediated by tonic activation of pre-synaptic NMDARs via three functionally interrelated MAPKs at the spinal cord level. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
Insights
Opioid-induced hyperalgesia and tolerance involve N-methyl-D-aspartate receptors (NMDARs) in the spinal cord. Mitogen-activated protein kinases (MAPKs) like ERK1/2, p38, and JNK mediate this effect, suggesting new therapeutic targets for pain management.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Opioid-induced hyperalgesia and analgesic tolerance limit the efficacy of μ-opioid receptor agonists.
- Opioids activate glutamate N-methyl-D-aspartate receptors (NMDARs) at primary afferent terminals, increasing nociceptive input.
- The precise signaling pathways for opioid-induced pre-synaptic NMDAR activation in the spinal dorsal horn are not fully understood.
Purpose of the Study:
- To investigate the role of Mitogen-Activated Protein Kinase (MAPK) signaling in opioid-induced pre-synaptic NMDAR activation following chronic morphine administration.
- To elucidate the mechanisms underlying opioid-induced hyperalgesia and analgesic tolerance at the spinal cord level.
Main Methods:
- Whole-cell recordings of excitatory post-synaptic currents (EPSCs) in rat spinal cord slices.
- Electrophysiological analysis of miniature and evoked EPSCs.
- Pharmacological inhibition of MAPK pathways (ERK1/2, p38, JNK) and NMDARs.
- Assessment of pain hypersensitivity and analgesic effects in rats.
- Co-immunoprecipitation assays to study protein interactions.
Main Results:
- Chronic morphine administration increased EPSC frequency and amplitude while reducing the paired-pulse ratio, indicating enhanced synaptic transmission.
- These changes were reversed by NMDAR antagonists and normalized by inhibiting ERK1/2, p38, or JNK.
- Inhibition of these MAPKs blocked morphine-induced pain hypersensitivity and attenuated analgesic tolerance.
- NMDARs formed protein complexes with ERK1/2, p38, and JNK, with increased physical interactions observed after chronic morphine treatment.
Conclusions:
- Opioid-induced hyperalgesia and analgesic tolerance are mediated by the tonic activation of pre-synaptic NMDARs in the spinal cord.
- Three functionally interrelated MAPKs—ERK1/2, p38, and JNK—are key signaling molecules in this process.
- Targeting these MAPK pathways represents a potential strategy for managing opioid-induced adverse effects in pain treatment.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Receptor-mediated Endocytosis
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Receptors: Overview
G-protein Coupled Receptors


